Core Viewpoint - The strategic partnership between Huaxi Bio and LG Household & Health Care focuses on synthetic biology technology to address skin aging and develop innovative solutions for the beauty industry [2][9]. Group 1: Partnership Details - Huaxi Bio and LG Household & Health Care signed a Memorandum of Understanding (MOU) on September 22, 2025, in Seoul, aiming to tackle skin aging through collaborative research [2]. - The partnership emphasizes the shift in the beauty industry from merely improving wrinkles to a new focus on "skin longevity," which aims to extend the healthy lifecycle of skin [2]. Group 2: Company Strengths - Huaxi Bio leverages its leading synthetic biology and biomanufacturing platform, along with advanced pilot conversion facilities, to develop bioactive substances closely related to human health [4]. - The company maintains a global leading position in hyaluronic acid while actively expanding into areas such as glycoscience, cell biology, and regenerative medicine for anti-aging technologies [4]. Group 3: LG Household & Health Care Innovations - LG Household & Health Care is recognized for its strong research capabilities in the beauty sector, focusing on cellular-level anti-aging and the efficacy of wild ginseng [6]. - The company has introduced innovative anti-aging research outcomes, such as NAD Power24, integrating cutting-edge research into high-end skincare products [6]. Group 4: Future Outlook - The collaboration aims to develop competitive innovative products that provide effective anti-aging solutions for global consumers [9]. - Both companies believe that combining their expertise will lead to groundbreaking anti-aging products for the global market [9].

Summary of the Health Supplement Industry Conference Call Industry Overview - The health supplement market in China is projected to exceed 200 billion RMB in 2024, with a year-on-year growth of 4%, indicating a growth-oriented industry despite a high base effect from 2023 [1][3][4] - The market is fragmented, with Tong Ren Tang as the leading player holding approximately 9% market share, although this share is declining [1][8] Market Dynamics - The health supplement industry is categorized into "blue hat" products (which can advertise efficacy but have restricted ingredients) and non-blue hat products (which rely on cross-border e-commerce for innovation) [1][6] - The rise of platforms like Douyin (TikTok) has significantly impacted the market, allowing new brands to emerge rapidly, particularly in functional ingredients like fish oil and Coenzyme Q10 [1][14] Consumer Trends - There has been a shift in consumer demographics, with younger consumers (middle-aged and young adults) becoming the primary market for health supplements, moving away from the traditional focus on older adults [2][16] - The demand from younger consumers is focused on improving sub-health conditions and enhancing personal image, with specific interests in gastrointestinal health and eye protection [1][16] Competitive Landscape - Major brands in the industry include Amway and Swisse, with Amway focusing on traditional dietary supplements through direct sales, while Swisse has gained market share through product innovation and online sales [9] - New brands are emerging rapidly, leveraging innovative products and efficient marketing strategies to compete against established players [15][20] Product Categories and Innovations - The market is segmented into traditional tonics, basic nutrients (vitamins), and other functional ingredients (probiotics, fish oil), with the latter experiencing rapid growth post-pandemic [1][6][7] - Technological innovations, such as synthetic biology, are reducing costs and expanding the application of ingredients like ergothioneine, which is now widely used in affordable skincare and health products [19] Future Trends and Investment Opportunities - The future of the health supplement industry is expected to focus on efficacy-driven products, with significant investment opportunities arising from this trend [27] - Companies like Lu Yu Chen are highlighted as strong investment candidates due to their deep industry insights and robust operational capabilities [27] Key Statistics - The cross-border e-commerce channel for health supplements is expected to grow by 80% in 2024, indicating a significant shift in sales channels [3][18] - The market for probiotics has exceeded 10 billion RMB, with a strong growth trajectory, while Coenzyme Q10 is currently valued at over 4 billion RMB [22] Conclusion - The health supplement industry in China is characterized by rapid growth, evolving consumer demographics, and increasing competition. The rise of digital platforms and technological innovations presents both challenges and opportunities for existing and new players in the market.

Core Viewpoint - Huaxi Biological has reported a seemingly contradictory financial performance for 2024, with total revenue of 5.371 billion yuan, a year-on-year decline of 11.61%, and a net profit of 174 million yuan, down 70.59%. However, the company increased its R&D investment by 4.46% to a record high of 466 million yuan, representing 8.68% of its revenue, positioning it among the leaders in A-shares [2][10]. Financial Performance - Total revenue for Huaxi Biological in 2024 was 5.371 billion yuan, a decrease of 11.61% year-on-year [2]. - Net profit fell to 174 million yuan, a significant drop of 70.59% [2]. - R&D investment reached 466 million yuan, marking a 4.46% increase and a historical high [2]. - The R&D expense ratio was 8.68%, placing the company at the forefront of the A-share market [2][10]. Business Strategy - The company aims to return to an entrepreneurial organization to awaken its innovative capabilities, as stated by Chairman Zhao Yan [2]. - Huaxi Biological's international revenue from raw materials reached 608 million yuan, a year-on-year increase of 17.65%, supported by FDA certification [5]. - The medical terminal business generated 1.44 billion yuan, a remarkable increase of 32.03%, becoming the largest revenue contributor [6]. - The functional skincare segment saw revenue decline by 31.62% to 2.569 billion yuan due to intensified market competition and channel adjustments [6]. R&D and Innovation - Huaxi Biological has established eight R&D platforms and holds 580 valid patents, with 392 applicable to its main business [7]. - The company is transitioning from a focus on hyaluronic acid to two foundational sciences: glycoscience and cell biology [9]. - The R&D team consists of 920 members, reflecting the company's commitment to long-term investment in innovation [10]. Market Position and Future Outlook - The FDA certification is expected to facilitate Huaxi Biological's expansion into high-end markets in Europe and the United States [4]. - The company is diversifying its business across four major fields: raw materials, medical devices, functional foods, and tissue engineering, creating a "cell-level anti-aging" ecosystem [9]. - Despite short-term profit pressures, Huaxi Biological announced a cash dividend of 52.62 million yuan, accounting for 30.19% of its net profit [9].

Group 1 - Norway celebrates its Constitution Day on May 17, marking the signing of the Norwegian Constitution in 1814, symbolizing independence and democratic spirit [1] - The 211th anniversary of Norway's Constitution Day was celebrated with events in Beijing and Shanghai, organized by the Norwegian Embassy in China, the Innovation Norway, and various enterprises [1][3] - NYO3, a core member of the Norwegian Health Products Group, focuses on innovative technology to redefine Omega-3 nutrition and promote the concept of "health and longevity" [1][3] Group 2 - Norway is known as a "long-lived country," with a long history of fish oil consumption, and Omega-3 is considered one of the secrets to longevity [3] - The Oslo Breakfast Program initiated by the Norwegian government in the early 20th century incorporated Omega-3 into children's dietary standards, establishing a foundation for national health [3] - NYO3 specializes in Antarctic krill oil, emphasizing the absorption benefits of its marine phospholipid structure, and has received multiple international quality certifications [3][5] Group 3 - Norway ranks high in gender equality, with female labor participation exceeding 80%, leading to a significant demand for anti-aging products among women [5] - NYO3 has partnered with NO-Age to launch the Ageless brand line, targeting early aging issues in women aged 25 and above, with innovative products that enhance absorption rates [5] - The Ageless Aurora Beauty Pills achieved top rankings in Tmall International's oral beauty category within the first month of launch and will be showcased at the 2025 Vitafoods Europe exhibition [5][6] Group 4 - To commemorate the 211th anniversary of Constitution Day, NYO3 launched a special campaign on Tmall International, offering consumers a chance to win health gifts, including a trip to Norway [6] - NYO3 aims to bridge cultural exchanges between China and Norway through its products, promoting a healthy Nordic lifestyle and enhancing global awareness of Norway [6]

真正优秀的成分，总会随着时间焕发新的生命力。 在护肤领域，透明质酸（ HA），也就是我们熟知的玻尿酸，堪称初代 "顶流巨星"。从保湿到抗皱，从修复到紧致，它的功效几乎覆盖了消费者对护肤 品的所有期待。然而，随着胜肽、烟酰胺等新兴成分的涌现，一时间，质疑声四起：曾经风靡护肤界的玻尿酸，如今是否还能保持它的优势？ 这种断层式领先表明，无论市场如何变化，透明质酸依然是品牌配方中的核心选择。 为什么透明质酸能够保持这样的地位？答案很简单 ——它不仅是一种经典成分，更是一种经过时间验证、安全可靠且功效显著的护肤原料。 透明质酸 的抗皱紧致 地位坚如磐石 数据不会撒谎。 根据中国香妆和用户说联合发布的《 2025原料成分趋势洞察榜单》，透明质酸稳坐"抗皱紧致"成分应用热度榜首。在2025年1-2月备 案的护肤品中，含有透明质酸的产品数量高达10562个，是第二名烟酰胺（5504个）的近两倍。 早期的透明质酸提取工艺复杂且成本高昂。 1949 年，Boas 从鸡冠中分离出透明质酸。提取 1g 透明质酸需要 200 公斤鸡冠（约 2 万只鸡），导致生 产成本极高，每公斤售价高达10万美元，被誉为"液体黄金"。 从 "液体黄金 ...

Core Insights - The event held at the Peninsula Hotel in Paris celebrated the "2024 Forbes 40 Women," focusing on women's leadership and resilience, with GEMO as a key participant showcasing its flagship product, the GEMO 4R Collagen Machine [1][2] Group 1: Event Overview - The "Forbes 40 Women" event is recognized as a global benchmark for women's influence, featuring 40 elite women from various sectors including technology, finance, and arts [2] - Notable attendees included Forbes CEO Dominique Busso and Olympic champion Ysaora Thibus, highlighting the event's significance in celebrating women's achievements [2] Group 2: GEMO's Brand Positioning - GEMO's participation and the presentation of the GEMO 4R Collagen Machine as the exclusive gift for awardees underscored the brand's alignment with high-achieving women and its commitment to redefining beauty standards [2][3] - The brand's philosophy emphasizes that true female leadership stems from the unity of inner energy and external excellence, resonating with the aspirations of modern women [2] Group 3: Product Innovation - The GEMO 4R Collagen Machine, developed in collaboration with LaClinic Montreux, utilizes advanced technologies such as sound, light, and electricity to set new standards in anti-aging solutions, promoting cellular-level rejuvenation [3] - The product aims to empower women to actively shape their beauty at every age, reflecting GEMO's core belief in being a "time sculptor" [3][6] Group 4: Market Performance - Despite a slowdown in the overall beauty industry, the high-end beauty device market is experiencing growth, with GEMO holding a 41% market share in the segment of devices priced over 10,000 yuan, marking three consecutive years of market share increase [4] - GEMO's commitment to safety and innovation has positioned it as a leader in the industry, with multiple international safety certifications enhancing its product reliability [4] Group 5: Future Outlook - GEMO's collaboration with Forbes reinforces its industry standing, distinguishing itself in a competitive market through unique technological barriers and a deep understanding of "female energy" [5] - The brand aims to continue leveraging technology to help women balance their professional and personal lives, promoting a holistic approach to beauty and self-discovery [6]

Core Viewpoint - GEMO Jinmo and LaClinic Montreux are collaborating to innovate in the field of cellular anti-aging technology, marking a significant advancement in high-end home beauty devices [1][5][17] Company Overview - GEMO Jinmo is recognized as a leading brand in the Swiss high-end anti-aging home beauty device market, partnering with LaClinic Montreux to enhance its product offerings [5][11] - LaClinic Montreux, founded by Dr. Michel E. Pfulg, is renowned for its personalized anti-aging treatments and is considered a benchmark in the global anti-aging field [11][13] Market Insights - The global anti-aging beauty market surpassed $60 billion in 2022, with a projected annual growth rate of 9.5% until 2030 [7] - In China, the anti-aging beauty device market exceeded 10 billion yuan in 2022, with expectations of over 20% annual growth in the next five years [7] Product Innovation - GEMO Jinmo has developed innovative products such as the GEMO Jinmo Collagen Machine, which integrates advanced technologies for effective cellular anti-aging [8][14] - The collaboration emphasizes a philosophy of "technology + experience + aesthetics," aiming to redefine cellular anti-aging technology in various scenarios [5][10] Strategic Collaboration - The partnership between GEMO Jinmo and LaClinic Montreux aims to create the world's first integrated medical and wellness care space, enhancing the customer experience [5][10] - Dr. Pfulg's visit to GEMO Jinmo's R&D center signifies a deepening of their strategic collaboration, reinforcing their commitment to advancing anti-aging technologies [1][17] Consumer Trends - There is a growing consumer demand for home beauty devices that are non-invasive, safe, and effective, leading to a shift towards high-end, professional-grade products [7][10] - GEMO Jinmo's focus on long-lasting, natural beauty aligns with changing consumer preferences in the anti-aging market [10][13]